HomeCompareNOVN vs SBUX

NOVN vs SBUX: Dividend Comparison 2026

NOVN yields 2125.40% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NOVN wins by $17531898098.48M in total portfolio value
10 years
NOVN
NOVN
● Live price
2125.40%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17531898098.63M
Annual income
$16,046,703,901,914,954.00
Full NOVN calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — NOVN vs SBUX

📍 NOVN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNOVNSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NOVN + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NOVN pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NOVN
Annual income on $10K today (after 15% tax)
$180,658.87/yr
After 10yr DRIP, annual income (after tax)
$13,639,698,316,627,710.00/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, NOVN beats the other by $13,639,698,316,571,746.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NOVN + SBUX for your $10,000?

NOVN: 50%SBUX: 50%
100% SBUX50/50100% NOVN
Portfolio after 10yr
$8765949049.40M
Annual income
$8,023,351,950,990,397.00/yr
Blended yield
91.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

NOVN
No analyst data
Altman Z
-6.8
Piotroski
4/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NOVN buys
0
SBUX buys
0
No recent congressional trades found for NOVN or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNOVNSBUX
Forward yield2125.40%2.75%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$17531898098.63M$157.5K
Annual income after 10y$16,046,703,901,914,954.00$65,840.13
Total dividends collected$17426965851.86M$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: NOVN vs SBUX ($10,000, DRIP)

YearNOVN PortfolioNOVN Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$223,240$212,539.85$11,107$407.21+$212.1KNOVN
2$4,673,200$4,434,333.16$12,512$626.87+$4.66MNOVN
3$91,753,856$86,753,532.14$14,366$978.69+$91.74MNOVN
4$1,690,067,758$1,591,891,132.54$16,929$1,557.50+$1690.05MNOVN
5$29,212,083,466$27,403,710,964.97$20,658$2,543.80+$29212.06MNOVN
6$473,930,931,126$442,674,001,816.98$26,406$4,302.22+$473930.90MNOVN
7$7,219,118,648,525$6,712,012,552,220.43$35,877$7,622.00+$7219118.61MNOVN
8$103,276,088,728,702$95,551,631,774,779.60$52,741$14,352.64+$103276088.68MNOVN
9$1,388,031,959,551,211$1,277,526,544,611,500.20$85,676$29,243.03+$1388031959.47MNOVN
10$17,531,898,098,634,750$16,046,703,901,914,954.00$157,513$65,840.13+$17531898098.48MNOVN

NOVN vs SBUX: Complete Analysis 2026

NOVNStock

Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. Novan, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.

Full NOVN Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this NOVN vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NOVN vs SCHDNOVN vs JEPINOVN vs ONOVN vs KONOVN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.